Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholder feedback

Re: Let's face the truth -

posted on Jan 14, 2009 03:45PM

The truth is that the USPTO revalidation of the 336 and 148 patents is the single most important thing that needs to happen for our little company to succeed. Complaining about where we are because of the actions of previous poor CEO management is not going to do any good at this time, it's all water under the bridge. No one really knows what we own and that includes the people at TPL and PTSC. If the patents are revalidated we might have somthing very special. If not then we all own a piece of a small penny stock company that may gross $6-$10 million a year with Holocom, Crossflo and the rest and in 5 years might be somthing if things fall into place. RG is doing a good job with what he has to work with and what he has control over. We're all in the same sail boat waiting for the wind to blow before we go anywhere. That's the truth.

All the best,

Steve

Share
New Message
Please login to post a reply